Efficacy and safety of a single occipital nerve blockade in episodic and chronic cluster headache: A prospective observational study | All the latest summaries on the portal Medznat.ru. :- Medznat
EN | RU
EN | RU

Help Support

By clicking the "Submit" button, you accept the terms of the User Agreement, including those related to the processing of your personal data. More about data processing in the Policy.
Back

Efficacy and safety of a single occipital nerve blockade in episodic and chronic cluster headache: A prospective observational study

Efficacy and safety of a single occipital nerve blockade in episodic and chronic cluster headache: A prospective observational study Efficacy and safety of a single occipital nerve blockade in episodic and chronic cluster headache: A prospective observational study
Efficacy and safety of a single occipital nerve blockade in episodic and chronic cluster headache: A prospective observational study Efficacy and safety of a single occipital nerve blockade in episodic and chronic cluster headache: A prospective observational study

Treatment options for cluster headache (CH) include acute, transitional and prophylactic strategies. 

See All

Key take away

In an occipital nerve block injection, a needle is inserted at the base of the skull and the medication is injected around the origin of greater occipital nerve. Throughout this research article, this nerve block proved to be highly promising for curbing the headaches.

Background

Treatment options for cluster headache (CH) include acute, transitional and prophylactic strategies. We assessed the efficacy and safety of a single occipital nerve block (ONB) in patients with episodic (eCH) and chronic CH (cCH).

Method

In this prospective, observational study 101 CH were treated with a single ONB using triamcinolone 10 mg and bupivacaine. Attack frequency, pain intensity and side effects were assessed at days 1 and 7 after ONB and thereafter weekly for 60 days until recurrence of attacks.

Result

Baseline mean daily attack frequency was 2.9 ± 2.5 (eCH) and 3.3 ± 2.9 (cCH), which was reduced to 0.7 ± 1.2 (eCH) and 1.1 ± 1.4 (cCH) after one day (p = 0.08 for group difference) and to 1.1 ± 1.6 (eCH) and 1.9 ± 2.3 (cCH) after seven days (p = 0.01 for group difference). In patients with eCH the pain-free period lasted longer compared to cCH (p = 0.004). There was no association between the presence of local anesthesia and treatment response (p = 0.88). No serious adverse events occurred.

Conclusion

ONB is an easy, safe and effective transitional treatment option in case of insufficient response of CH to treatment both in patients with eCH and cCH. Patients with eCH have a better and more sustainable treatment response.

Source:

Cephalalgia

Article:

Efficacy and safety of a single occipital nerve blockade in episodic and chronic cluster headache: A prospective observational study

Authors:

Charly Gaul et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en
Try: